Treatment of idiopathic pulmonary fibrosis: is there anything new?

MM Abdelaziz, YS Samman, SO Wali… - …, 2005 - Wiley Online Library
Idiopathic pulmonary fibrosis (IPF) is a specific form of chronic fibrosing interstitial
pneumonia of unknown aetiology and is associated with the histological picture of usual …

Idiopathic pulmonary fibrosis: current and future treatment options

HR Davies, L Richeldi - American Journal of Respiratory Medicine, 2002 - Springer
Idiopathic pulmonary fibrosis (IPF) is a chronic condition of unknown etiology with an
unfavorable outcome from progressively deteriorating respiratory function, leading ultimately …

[HTML][HTML] Treatment of idiopathic pulmonary fibrosis

ST Abuserewa, R Duff, G Becker - Cureus, 2021 - ncbi.nlm.nih.gov
Idiopathic pulmonary fibrosis (IPF) is a chronic, progressive, fibrosing interstitial pneumonia
of unknown cause, occurring in adults and limited to the lungs. In the past, treatment was …

Idiopathic pulmonary fibrosis: an update

OJ Dempsey, KM Kerr, L Gomersall… - Journal of the …, 2006 - academic.oup.com
Idiopathic pulmonary fibrosis (IPF) is a chronic lung condition of uncertain aetiology that
should be considered in the differential diagnosis of patients who experience …

Idiopathic pulmonary fibrosis: newer concepts and management strategies.

R Sharma, R Guleria, JN Pande - … Indian journal of chest diseases & …, 2003 - europepmc.org
Idiopathic pulmonary fibrosis (IPF) is defined as a specific form of chronic fibrosing interstitial
pneumonia limited to the lung and associated with the histologic appearance of usual …

Characteristics and management of idiopathic pulmonary fibrosis: INSIGHTS-IPF registry

J Behr, MM Hoeper, M Kreuter, J Klotsche… - Deutsche …, 2012 - europepmc.org
Idiopathic pulmonary fibrosis (IPF), a manifestation of chronic progressive fibrosing
interstitial pneumonia, is with a prevalence of 2-29 cases per 100,000 individuals a rare …

Idiopathic pulmonary fibrosis: treatment update

OJ O'Connell, MP Kennedy, MT Henry - Advances in therapy, 2011 - Springer
Idiopathic pulmonary fibrosis (IPF) is the most common of the idiopathic interstitial
pneumonias. Despite multiple recent clinical trials, there is no strong evidence supporting a …

Interferon gamma-1b in the treatment of idiopathic pulmonary fibrosis

MA Pacanowski, GW Amsden - Annals of Pharmacotherapy, 2005 - journals.sagepub.com
Objective: To examine the clinical aspects of idiopathic pulmonary fibrosis (IPF) and the
efficacy and safety of interferon gamma-1b (IFNγ− 1b) in its treatment. Data Sources …

[HTML][HTML] End of an ERA: lessons from negative clinical trials in idiopathic pulmonary fibrosis

PW Noble, L Richeldi, N Kaminski - American journal of respiratory …, 2011 - atsjournals.org
The article by King and coworkers in this issue of the Journal (pp. 92–99) reports the results
of BUILD-3, a large, randomized, and placebo-controlled trial that evaluated the efficacy of …

[PDF][PDF] Idiopathic pulmonary fibrosis: What primary care physicians need to know

LB Tolle, BD Southern, DA Culver, JC Horowitz - Cleve Clin J Med, 2018 - academia.edu
Idiopathic pulmonary fibrosis (IPF) is a specific type of fibrosing interstitial pneumonia of
unknown cause. It is usually chronic and progressive, tends to affect mainly adults over age …